| Online-Ressource |
Verfasst von: | Arians, Nathalie [VerfasserIn]  |
| Oelmann-Avendano, Jan Tobias [VerfasserIn]  |
| Schmitt, Daniela [VerfasserIn]  |
| Meixner, Eva [VerfasserIn]  |
| Wark, Antje [VerfasserIn]  |
| Hörner-Rieber, Juliane [VerfasserIn]  |
| El-Shafie, Rami [VerfasserIn]  |
| Lang, Kristin [VerfasserIn]  |
| Wallwiener, Markus [VerfasserIn]  |
| Debus, Jürgen [VerfasserIn]  |
Titel: | Evaluation of uterine brachytherapy as primary treatment option for elderly patients with medically inoperable endometrial cancer |
Titelzusatz: | a single-center experience and review of the literature |
Verf.angabe: | Nathalie Arians, Jan Tobias Oelmann-Avendano, Daniela Schmitt, Eva Meixner, Antje Wark, Juliane Hoerner-Rieber, Rami A. El Shafie, Kristin Lang, Markus Wallwiener and Jürgen Debus |
E-Jahr: | 2020 |
Jahr: | 15 August 2020 |
Umfang: | 13 S. |
Fussnoten: | Gesehen am 03.12.2020 |
Titel Quelle: | Enthalten in: Cancers |
Ort Quelle: | Basel : MDPI, 2009 |
Jahr Quelle: | 2020 |
Band/Heft Quelle: | 12(2020,8) Artikel-Nummer 2301, 13 Seiten |
ISSN Quelle: | 2072-6694 |
Abstract: | We aimed to gain more evidence regarding the feasibility, toxicity, and oncological outcome of primary brachytherapy in patients with medically inoperable endometrial cancer. Thirteen patients receiving primary brachytherapy ± external beam radiotherapy (EBRT) for endometrial cancer due to medical inoperability were identified. The Kaplan–Meier method was used to estimate overall survival (OS), progression-free survival (PFS), and local failure-free survival (LFFS). Univariate outcome analyses were performed using the log-rank test. Peri-interventional complications, acute and chronic toxicities were evaluated. Additionally, we performed a Pubmed search and review of the literature of the last 10 years. Mean age at time of diagnosis was 73.9 years (60.4–87.1 years). Eleven patients were staged FIGO IA/B and one patient each with FIGO IIIA and IIIC. Kaplan–Meier-estimated 2-/5-year LFFS were 76.2%/56.4%, respectively. High grading correlated with a worse LFFS (p = 0.069). Kaplan–Meier-estimated 2-/5-year PFS were 76.9%/53.8% and 2-/5-year-OS were 76.9%/69.2%, respectively. No acute toxicities > grade II and only two late toxicities grade II/III occurred. We observed three peri-interventional complications. The available evidence suggests high rates of local control after definitive brachytherapy for inoperable endometrial cancer with a favorable toxicity profile. Definitive brachytherapy +/− EBRT should be considered as the preferred approach for this patient group. |
DOI: | doi:10.3390/cancers12082301 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext ; Verlag: https://doi.org/10.3390/cancers12082301 |
| Volltext: https://www.mdpi.com/2072-6694/12/8/2301 |
| DOI: https://doi.org/10.3390/cancers12082301 |
Datenträger: | Online-Ressource |
Sprache: | eng |
Sach-SW: | definitive radiotherapy |
| elderly patients |
| endometrial cancer |
| functional inoperability |
| intrauterine brachytherapy |
K10plus-PPN: | 1741925789 |
Verknüpfungen: | → Zeitschrift |
Evaluation of uterine brachytherapy as primary treatment option for elderly patients with medically inoperable endometrial cancer / Arians, Nathalie [VerfasserIn]; 15 August 2020 (Online-Ressource)